Aharon Schwartz - 10 Jun 2025 Form 4 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role: Director
Signature: /s/ Joseph R. Magnas, Attorney-in-Fact
Issuer symbol: PLX
Transactions as of: 10 Jun 2025
Net transactions value: +$205,884
Form type: 4
Filing time: 12 Aug 2025, 16:30:07 UTC
Previous filing: 03 Oct 2023
Next filing: 04 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Schwartz Aharon	Director	C/O PROTALIX BIOTHERAPEUTICS, INC., 2 SNUNIT STREET SCIENCE PARK, POB 455, CARMIEL, ISRAEL	/s/ Joseph R. Magnas, Attorney-in-Fact	12 Aug 2025	0001625184

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLX	Common Stock	Purchase	$205,884	+129,000	+74%	$1.60	303,000	10 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $1.60 to $1.575 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.